Growth Investing
It’s no secret that biopharma has been (and will continue to be) fertile ground for mergers and acquisitions. Here’s what you need to know... Read More
It’s no secret that biopharma has been (and will continue to be) fertile ground for mergers and acquisitions. Here’s what you need to know... Read More
Health and Human Services announced this week that it’s asking the Drug Enforcement Administration to move cannabis from Schedule I to Schedule III. Read More
Health and Human Services announced this week that it’s asking the Drug Enforcement Administration to move cannabis from Schedule I to Schedule III. Read More